VUF-6002
VUF-6002 is a chemical compound that acts as a selective agonist for the histamine H4 receptor. It has been used in scientific research to investigate the role of the H4 receptor in various physiological and pathological processes.
Chemical Properties[edit | edit source]
VUF-6002 is characterized by its specific binding affinity to the histamine H4 receptor, distinguishing it from other histamine receptor subtypes such as H1, H2, and H3 receptors. The molecular structure of VUF-6002 allows it to selectively activate the H4 receptor, making it a valuable tool in pharmacological studies.
Pharmacological Effects[edit | edit source]
The activation of the histamine H4 receptor by VUF-6002 has been shown to modulate immune responses, particularly in the context of inflammation and allergic reactions. Research indicates that H4 receptor agonists like VUF-6002 can influence the behavior of various immune cells, including mast cells, eosinophils, and T cells.
Research Applications[edit | edit source]
VUF-6002 has been utilized in preclinical studies to explore its potential therapeutic applications. These studies have investigated its effects on conditions such as asthma, allergic rhinitis, and chronic pruritus. By understanding the role of the H4 receptor in these conditions, researchers aim to develop new treatments that target this receptor.
Safety and Toxicology[edit | edit source]
As with any experimental compound, the safety and toxicological profile of VUF-6002 must be thoroughly evaluated. Initial studies suggest that it has a favorable safety profile, but further research is necessary to fully understand its potential side effects and long-term impact.
Conclusion[edit | edit source]
VUF-6002 is a significant compound in the study of histamine receptors, particularly the H4 receptor. Its selective agonist properties make it a valuable tool for researchers investigating the role of the H4 receptor in immune responses and related diseases.
See Also[edit | edit source]
References[edit | edit source]
External Links[edit | edit source]
-
 | This medical article is a stub. You can help WikiMD by expanding it. |
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
